Benzinga’s Top Ratings Upgrades, Downgrades For September 13, 2022
Upgrades
See all analyst ratings upgrades.
Where Health Catalyst Stands With Analysts
Analysts have provided the following ratings for Health Catalyst (NASDAQ:HCAT) within the last quarter:
Short Volatility Alert: Health Catalyst, Inc.
On Friday, shares of Health Catalyst, Inc. (NASDAQ: HCAT) experienced volatile short activity. After the activity, the stock price went down -2.55% to $11.48.
The overall sentiment for HCAT has been Bearish.
Health Catalyst’s Return On Capital Employed Overview
Benzinga Pro data, Health Catalyst (NASDAQ:HCAT) reported Q2 sales of $70.63 million. Earnings fell to a loss of $33.43 million, resulting in a 48.85% decrease from last quarter.
Why Cooper-Standard Is Trading Higher By 70%, Here Are 81 Stocks Moving In Friday’s Mid-Day Session
Gainers
Assure Holdings Corp. (NASDAQ: IONM) shares jumped 88.8% to $3.9650 after jumping around 104% on Thursday.
Warner Bros. Discovery, Twilio, Monster Beverage And Some Other Big Stocks Moving Lower On Friday
Health Catalyst, Inc. (NASDAQ: HCAT) fell 33.5% to $12.14 after the company issued weak sales forecast and announced a $40 million share repurchase program. JP Morgan and Stifel also downgraded the stock.
Markets Open Lower; U.S. Economy Adds Higher-Than-Expected Jobs In July
U.S. stocks traded lower this morning, following the release of jobs data
Synaptics To $205? Plus Stifel Cuts Twilio’s PT From $200 To This Level
Stifel cut the price target for Twilio Inc. (NYSE: TWLO) from $200 to $90. Twilio shares fell 9.6% to $88.75 in pre-market trading.